Disease in Biological Technology

Abbott HIV Test Demonstrates Earlier Disease Detection

CHICAGO, July 22 /PRNewswire-FirstCall/ -- Research presented today at the American Association for Clinical Chemistry annual meeting shows that an assay developed by Abbott for simultaneous detection of both HIV antigens and antibodies reduced the detection window by zero to nine days i...

EnVivo Pharmaceuticals Announces Reversal of Cognitive Deficits in Alzheimer's Disease Transgenic Mouse Model With Gamma-Secretase Modulator

VIENNA, July 14 /PRNewswire/ -- EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD) the reversal of behavioral deficits observed in an Alzheimer's disease transgenic animal model after chronic oral dosing of a propr...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

VIENNA, Austria, July 14 /PRNewswire-FirstCall/ -- Elan Corporation, plc (NYSE: ELN ) and Wyeth (NYSE: WYE ) presented information this week at the Alzheimer Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) from seven posters and one podium presentation ab...

Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in Vienna, Austria

COLUMBIA, Md., July 10 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it will conduct a conference call for investors to discuss DHA research recently presented at the International Conference on Alzheimer's Disease. The call will take place July ...

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives

Three-of-Four Patients Surveyed Experience Daily Pain From Rheumatoid Arthritis Despite Current Treatment; Findings Unveiled at the European League Against Rheumatism Annual Congress of Rheumatology COPENHAGEN, Denmark, June 10 /PRNewswire-FirstCall/ -- Results from the Rheumatoid Arthritis: ...

Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced results of the Phase 2 study of Zerenex (ferric citrate) for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on thri...

UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows

CHICAGO, June 1 /PRNewswire/ -- UCB, Inc. and the Crohn's Disease Working Group (CDWG) today announced the four recipients of the 2009 Research Awards in Inflammatory Bowel Disease (IBD) for Gastroenterology (GI) Fellows, who each will receive a one-year research grant for their original clinica...

Zeus to Present at Digestive Disease Week in Chicago

Zeus Research & Development will be one of the presenters at Digestive Disease Week, addressing the topic of invention of new devices in interventional gastroenterology ORANGEBURG, S.C., May 29 /PRNewswire/ -- Zeus, Inc., a leader in polymer extrusions and material science, announces it h...

Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)

Studies to be presented on safety and efficacy of SpyGlass System for diagnostic and therapeutic procedures throughout pancreatico-biliary system NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that 14 abstracts and additional clini...

Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week

THE WOODLANDS, Texas, May 27 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that the company will be giving oral presentations on two of its c...

China-Biotics, Inc. to Attend Digestive Disease Week 2009

SHANGHAI, May 26 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced that management will attend ...

Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available

Free Access Given to Support the Global R&D and Healthcare Community PHILADELPHIA and LONDON, May 20 /PRNewswire/ -- In support of the efforts of the global healthcare community working to prevent and address outbreaks such as the current Influenza A (H1N1) flu outbreak, the Healthcare an...

ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

First-in-class Oral Therapeutic for IBD with Novel Mode of Action MOUNTAIN VIEW, Calif., May 19 /PRNewswire/ -- ChemoCentryx, Inc., today announced that data from the company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) Phase II/III clinical tria...

Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States

Non-Profit Biotech Calls on the Entire ALS Community to Join a Nationwide Network of Independence Day Events CAMBRIDGE, Mass., May 18 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced its BBQ For ALS Awareness , is a national initiative designed to increas...

The Crohn's & Colitis Foundation of America and Shire Launch Virtual 'IBD March on the Hill' to Increase Funding for Digestive Disease Research

Virtual March Connects 'IBD Day on the Hill' Advocates in Washington, D.C. with Online Supporters PHILADELPHIA, May 6 /PRNewswire-FirstCall/ -- Today the Crohn's & Colitis Foundation of America (CCFA) and Shire plc (LSE: SHP, Nasdaq: SHPGY ) joined forces to launch the first-ever virt...

New Survey Reveals Gap in Understanding of Alzheimer's Disease Risk and Prevention Among Most Vulnerable Populations

Research presented to the 2009 Congressional Black Caucus Spring Health Braintrust finds African American and Hispanic adults are misinformed about Alzheimer's but support a screening test WOODCLIFF LAKE, N.J., May 4 /PRNewswire/ -- African American and Hispanic adults are more concerned abou...

ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs

FREDERICK, Md., April 29 /PRNewswire/ -- ImQuest BioSciences and Arisyn Therapeutics jointly announced today that they have entered into a strategic drug development partnership to provide support necessary to develop Arisyn's portfolio of novel inhibitors for the treatment of infectious disease a...

Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)

STOCKHOLM, Sweden, April 29 /PRNewswire/ -- - Results to be Presented at World Congress of Nephrology 2009 Pharmalink AB announced today that it has completed its open Phase II trial evaluating the efficacy and safety of Nefecon(R) in IgA nephropathy, a glomerulonephritis leading...

Ocera Therapeutics Presents Data on AST-120 in Patients With Hepatic Encephalopathy at the European Association for the Study of Liver Disease Annual Meeting

The Company also Initiates the Phase 2b ASTUTE Clinical Trial for Mild Hepatic Encephalopathy SAN DIEGO, April 28 /PRNewswire/ -- Ocera Therapeutics, Inc., a privately held biopharmaceutical company, announced that data from its phase 2 study of AST-120 for the treatment of patients with low-...

United States Recognizes Leading Scottish Scientist for Disease Research

Sir Philip Cohen to be inducted into National Academy of Sciences for groundbreaking work in biochemistry and biology WASHINGTON, April 22 /PRNewswire/ -- Sir Philip Cohen of Scotland's University of Dundee will be inducted into the U.S. National Academy of Sciences (NAS) during its 146th ...

VisEn Launches Next-Generation Fast ('Fluorescence Activatible Sensor Technology') Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo

MMPSense(TM) 750 FAST is Presented at AACR 100th Annual Meeting BEDFORD, Mass., April 20 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the introduction of its new FAST ("Fluorescent Activatible Sensor Technolog...

Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology

OMAHA, Neb., April 2 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO). In a peer-reviewed paper published in the February 2009 issue of the journal Human Mutation, a team at Weill Cornell Medical College New York describes in detail the key advantages of using Transgenomic'...

Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients.

- Journal of Neuroscience paper describes role of Zinc in developing Alzheimer's - MELBOURNE, Australia, April 1 /PRNewswire-FirstCall/ -- Prana Biotechnology (ASX:PBT; Nasdaq: PRAN ) today announced that an independent study conducted by researchers at the University of California, Irvine...

Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting

Data provide support for expected Phase 3 program CRANBURY, N.J., March 28 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD ) announced today positive results from its ongoing Phase 2 extension study of its investigational drug, Amigal(TM) (migalastat HCL) for Fabry disease. The...

New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando

Results of five clinical studies evaluating the predictive value of VENDYS®, the new FDA-approved cardiovascular test, will be presented at the 2009 Annual Scientific Sessions of the American College of Cardiology in Orlando, Florida. The studies, amazingly, show that a simple, inexpensive te...

TauTaTis Discovers Potent Inhibitor of Parkinson's Disease Gene Activity

JACKSONVILLE, Fla., March 16 /PRNewswire/ -- TauTaTis, Inc. announces that its lead compound for inhibition of tau protein pathology, the specific neurodegenerative process in Alzheimer's Disease, has been recognized as the most potent inhibitor of the activity of the Parkinson's Disease gene LRRK...

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

SYMBICORT provides a new, fast-acting(1) combination treatment option for millions of Americans with debilitating lung disease WILMINGTON, Del., Feb. 27 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) today announced that the U.S. Food and Drug Administration (FDA) has approved SYMBICO...

Tiny 'lab-on-a-chip' detects pollutants, disease and biological weapons

For centuries, animals have been our first line of defense against toxins. A canary in a coalmine served as a living monitor for poisonous gases. Scientists used fish to test for contaminants in our water. Even with modern advances, though, it can take days to detect a fatal chemical or organis...

VAP Cholesterol Test Helps In Search For New Heart Disease Drugs

Peer-reviewed journal, Science, reports that advanced cholesterol test aids in identifying connection between improved lipid profile and heart protection BIRMINGHAM, Ala., Feb. 16 /PRNewswire/ -- Using the VAP Cholesterol Test from Atherotech, Inc., University of Maryland researchers h...

Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant

NOVATO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced results from its Phase 2 multi-center, randomized, double-blind, placebo-controlled clinical study of 6R-BH4 in patients with symptomatic peripheral arterial disease (PAD). There was no...

Chronic Lung Disease - Axentis Pharma Attracts Investment Interest

ZURICH, February 2 /PRNewswire/ -- Axentis Pharma AG is to present its recent successes in developing and financing a new therapeutic formulation for treating chronic lung disease at the 2nd Annual European Life Science CEO Forum in Zurich, Switzerland. This invited talk comes just three weeks...

Traditional Risk Factors Often Miss Heart Disease Warning Signs

VAP(R) Cholesterol Test helps physicians identify emerging risk factors better than standard cholesterol test and traditional risk factors, study shows BIRMINGHAM, Ala., Jan. 30 /PRNewswire/ -- Traditional risk factors such as age, standard cholesterol levels and blood pressure do a poor jo...

New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns

Study Published in British Medical Journal Indicates Masimo SET May Also Reduce the Need for Pre-Operative Neonatal Intensive Care and Prevent Long-term Neurological Morbidity IRVINE, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry and...

New Health Retreat Gives a Fresh Attitude Towards Disease Prevention

CAPE TOWN, South Africa, January 28 /PRNewswire/ -- - Guests Will Bounce Back to Health Using Mini-Trampolines as Part of Unique Therapy Staying healthy in these stressful times is a challenge in itself but the launch of Fresh Attitude Health Retreats early in 2009 may provide pa...

GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle(TM) platform

TORONTO, Jan. 13 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced it has been granted U.S. Patent # 7,473,528 entitled "Method for the detection ...

Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates

Public Health Physician Spent Last 10 Years Helping Implement World Bank HIV/AIDS and Malaria Initiatives CAMBRIDGE, Mass., Jan. 8 /PRNewswire/ -- Abt Associates announced that Dr. John Osika has joined the company as a Principal Associate and HIV/AIDS and Infectious Disease Advisor. Dr. Osi...

Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target

SEATTLE, Jan. 6 /PRNewswire/ -- Omeros Corporation today announced that The Michael J. Fox Foundation has awarded it a $465,000 grant against milestones to support the Company's collaboration with The Parkinson's Institute to evaluate Omeros' recent discovery of a new target for the treatment of P...

Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development

LAUSANNE, Switzerland, December 4 /PRNewswire/ -- AC Immune SA, a leader in Alzheimer's disease drug development, announced today that the World Economic Forum has elected AC Immune as Technology Pioneer 2009 for its accomplishments as an innovation leader and for its breakthrough technologies tha...

New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development

SCOTTSDALE, Ariz., Dec. 2 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for Parkinson's diseas...

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies

PARIS, November 28 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients acceler...